logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Paice, Alistair
    Born in September 1969
    Individual (1 offspring)
    Officer
    2023-06-21 ~ now
    OF - Director → CIF 0
  • 2
    Moore, Robert Justin
    Born in March 1971
    Individual (2 offsprings)
    Officer
    2021-09-13 ~ now
    OF - Director → CIF 0
  • 3
    Prest, Kerry Janet
    Born in April 1979
    Individual (2 offsprings)
    Officer
    2025-09-11 ~ now
    OF - Director → CIF 0
  • 4
    Mamet, Isabelle
    Born in May 1964
    Individual (2 offsprings)
    Officer
    2023-06-21 ~ now
    OF - Director → CIF 0
  • 5
    91, Hegenheimermattweg, Allschwil, Switzerland
    Corporate (1 offspring)
    Person with significant control
    2021-07-16 ~ now
    PE - Ownership of voting rights - 75% or moreCIF 0
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
Ceased 2
  • 1
    Graham, Peter
    Market Access Director born in December 1966
    Individual
    Officer
    2023-06-21 ~ 2024-05-10
    OF - Director → CIF 0
  • 2
    Groenewoud, Arno
    Senior Vice President born in October 1971
    Individual
    Officer
    2021-07-16 ~ 2021-09-13
    OF - Director → CIF 0
parent relation
Company in focus

IDORSIA PHARMACEUTICALS UK LIMITED

Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Property, Plant & Equipment
6,893 GBP2024-12-31
8,911 GBP2023-12-31
Debtors
4,987,497 GBP2024-12-31
1,544,443 GBP2023-12-31
Cash at bank and in hand
889,026 GBP2024-12-31
775,221 GBP2023-12-31
Current Assets
7,495,194 GBP2024-12-31
2,653,881 GBP2023-12-31
Creditors
Current, Amounts falling due within one year
-6,489,522 GBP2024-12-31
Net Current Assets/Liabilities
1,005,672 GBP2024-12-31
968,212 GBP2023-12-31
Total Assets Less Current Liabilities
1,012,565 GBP2024-12-31
977,123 GBP2023-12-31
Equity
Called up share capital
26,000 GBP2024-12-31
26,000 GBP2023-12-31
Share premium
574,000 GBP2024-12-31
574,000 GBP2023-12-31
Other miscellaneous reserve
551,825 GBP2024-12-31
385,736 GBP2023-12-31
Retained earnings (accumulated losses)
-139,260 GBP2024-12-31
-8,613 GBP2023-12-31
Equity
1,012,565 GBP2024-12-31
977,123 GBP2023-12-31
Audit Fees/Expenses
27,000 GBP2024-01-01 ~ 2024-12-31
22,800 GBP2023-01-01 ~ 2023-12-31
Average Number of Employees
142024-01-01 ~ 2024-12-31
142023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Other
10,088 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Other
3,195 GBP2024-12-31
1,177 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Other
2,018 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Other
6,893 GBP2024-12-31
8,911 GBP2023-12-31
Trade Debtors/Trade Receivables
Current
623,240 GBP2024-12-31
50,981 GBP2023-12-31
Amounts Owed By Related Parties
3,726,228 GBP2024-12-31
Current
1,184,788 GBP2023-12-31
Prepayments/Accrued Income
Current
53,954 GBP2024-12-31
8,328 GBP2023-12-31
Trade Creditors/Trade Payables
Current
2,895,974 GBP2024-12-31
753,681 GBP2023-12-31
Amounts owed to group undertakings
Current
2,358,414 GBP2024-12-31
372,157 GBP2023-12-31
Corporation Tax Payable
Current
16,731 GBP2024-12-31
60,642 GBP2023-12-31
Other Taxation & Social Security Payable
Current
109,421 GBP2024-12-31
73,355 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
1,011,725 GBP2024-12-31
414,837 GBP2023-12-31
Par Value of Share
Class 1 ordinary share
1 GBP2024-01-01 ~ 2024-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
26,000 shares2024-12-31
26,000 shares2023-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
0 GBP2024-12-31

  • IDORSIA PHARMACEUTICALS UK LIMITED
    Info
    Registered number 13515638
    20 Eastbourne Terrace, London W2 6LG
    PRIVATE LIMITED COMPANY incorporated on 2021-07-16 (4 years 7 months). The company status is Active.
    The last date of confirmation statement was made at 2024-07-15
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.